Useful resources |
Ursodeoxycholic acid for cystic fibrosis-related liver disease (Cochrane Review) ABSTRACT Background: Cystic fibrosis-related liver disease peaks in adolescence with up to 20% of people with cystic fibrosis developing chronic liver disease. Early changes in the liver may ultimately result in end-stage liver disease with people needing transplantation . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |